Abstract
ABSTRACTEmbolization using microspheres plays an important role in interventional cancer therapy. The drug-eluting embolization microspheres were prepared via reverse suspension crosslinking of gelatin, followed by modification of the cross-linked microspheres. The microspheres displayed regular spherical shapes with size distribution ranging from 180 μm to 350 μm. The negatively charged groups (COO−) were introduced into the microspheres which could load positively charged doxorubicin with loading rates as high as 26.1% and 34.0% in 1 and 12 h, respectively. The high drug-loading rates were ascribed to ionic interaction between carboxyl groups and doxorubicin. The drug release profile showed the modified microspheres (MMS) have a sustained release manner compared with non-MMS in phosphate buffered saline (PBS). The MMS were almost completely degradated after 20 days. Cytotoxicity assay certified that the MMS were non-cytotoxic, and could be potentially used as biocompatible materials.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
